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Proper regulation of chromatin structure is neces-
sary for the maintenance of cell type-specific gene
expression patterns. The embryonic stem cell (ESC)
expression pattern governs self-renewal andpluripo-
tency. Here, we present an RNAi screen in mouse
ESCs of 1008 loci encoding chromatin proteins. We
identified 68 proteins that exhibit diverse phenotypes
upon knockdown (KD), including seven subunits of
the Tip60-p400 complex. Phenotypic analyses
revealed that Tip60-p400 is necessary to maintain
characteristic features of ESCs. We show that p400
localization to the promoters of both silent and active
genes is dependent upon histone H3 lysine 4 trime-
thylation (H3K4me3). Furthermore, the Tip60-p400
KD gene expression profile is enriched for develop-
mental regulators and significantly overlaps with
that of the transcription factor Nanog. Depletion of
Nanog reduces p400 binding to target promoters
without affecting H3K4me3 levels. Together, these
data indicate that Tip60-p400 integrates signals
from Nanog and H3K4me3 to regulate gene expres-
sion in ESCs.
INTRODUCTION
ESCs are derived from the inner cell mass (ICM) of the blasto-
cyst-stage embryo and are defined by two properties: self-re-
newal, the ability to proliferate without a change in phenotype,
and pluripotency, the ability to differentiate into any cell in the
organism (Niwa, 2007). Because of these properties, ESCs are
regarded as a potential source of material for stem cell therapies.
A molecular understanding of the factors necessary for ESC
self-renewal and pluripotency is essential for moving toward
the implementation of such therapies.
Transcription factors (TFs) and chromatin regulatory proteins
play a major role in regulation of self-renewal by maintaining an
ESC-specific gene expression pattern (Niwa, 2007; Spivakov
and Fisher, 2007). Several TFs like Oct4, Sox2, Foxd3, and
Stat3 are required for pluripotency and self-renewal. Another162 Cell 134, 162–174, July 11, 2008 ª2008 Elsevier Inc.TF, Nanog, is necessary for robust self-renewal, as Nanog
mutant ESCs show an increased frequency of differentiated cells
in the population (Chambers et al., 2007). In contrast, the role of
chromatin regulation in these processes is not as well under-
stood. In ESCs, Polycomb group (PcG) proteins directly repress
a large number of genes induced during development, including
TFs that have the potential to promote differentiation (Boyer
et al., 2006). Like Nanog mutant ESCs, PcG mutant ESCs con-
tinue to proliferate in an undifferentiated state with an increased
frequency of differentiated cells, indicating that PcG-mediated
repression is not essential for ESC self-renewal (Morin-Kensicki
et al., 2001; Pasini et al., 2007).
Many developmental genes that are silent in ESCs are
marked by histone modifications associated with both tran-
scriptional activation and repression (Bernstein et al., 2006).
PcG proteins direct trimethylation of histone H3 at lysine 27
(H3K27me3), a repressive mark, near the transcription start
sites (TSS) of their targets (Bernstein et al., 2006; Boyer et al.,
2006). Histone H3 lysine 4 trimethylation (H3K4me3), a mark
generally associated with expression, is also present at the
TSS of most of these genes (Bernstein et al., 2006). It is thought
that the presence of both activating and repressive chromatin
marks keeps these developmental regulators silent in ESCs,
but poised for activation should they receive the appropriate
cues.
In addition to PcG proteins, a small set of other chromatin
regulatory proteins has been implicated in ESC self-renewal or
pluripotency. ESCs mutant for Mbd3, a component of the
NuRD corepressor complex, can proliferate normally in an undif-
ferentiated state but are impaired in their ability to differentiate,
indicating a defect in pluripotency (Kaji et al., 2006). Mutation
of genes encoding subunits of the Swi/Snf family of ATP-depen-
dent chromatin remodeling complexes, Brg1, Baf47/Snf5, and
Baf155, results in peri-implantation lethality (Bultman et al.,
2000; Guidi et al., 2001; Kim et al., 2001; Klochendler-Yeivin
et al., 2000; Roberts et al., 2000), consistent with a defect in
self-renewal, pluripotency or derivation of the ICM. Embryos
lacking Tip60 and Trrap, two components of the Tip60-p400 his-
tone acetyltransferase (HAT) and nucleosome remodeling com-
plex, also die before implantation (Gorrini et al., 2007; Herceg
et al., 2001), suggesting a role for this complex in early develop-
ment. In sum, these data suggest roles for chromatin regulatory
complexes in ESC self-renewal, pluripotency and differentiation.
Figure 1. Examples of Knockdown Phenotypes in ESCs
(A) esiRNAs silence effectively in ESCs. Brightfield and GFP fluorescence images of ESCs bearing an EGFP transgene transfected with indicated esiRNAs.
Images were obtained after 4 days of KD, except for Polr2A, which was imaged after 2 days.
(B) Western blotting of indicated proteins in ESCs knocked down as in (A). The asterisk indicates a background band in the Oct4 blot, which serves as a loading
control.
(C) Examples of phenotypes from the esiRNA screen. ESCsweremock-transfected or transfectedwith the indicated esiRNAs and imaged after 4 days. Scale bars
equal 140 mm.However, a direct examination of ESCs lacking individual
chromatin regulators is necessary to identify and understand
their functions.
Here, we describe a large-scale RNAi screen in ESCs, in which
we examine the roles of 1008 loci encoding chromatin proteins in
ESCs. We report 68 genes with KD phenotypes, most of which
were not previously known to function in ESCs. In depth analysis
of one group of hits encoding the Tip60-p400 complex reveals
that ESCs lacking this complex continue to express pluripotency
TFs but lack most of the defining characteristics of ESCs. We
find that Tip60-p400 is required for repression of a large group
of genes expressed during differentiation. Binding of p400 to
its targets requires both H3K4me3 and the pluripotency TF
Nanog. These data broaden the landscape of factors regulating
ESC identity and define an important role for Tip60-p400 in the
Nanog transcriptional network.RESULTS
RNAi Screening in ESCs
To identify chromatin proteins important in ESCs, we carried out
an RNAi screen for proteins necessary for normal ESC growth.
We employed esiRNAs, which exhibit minimal off-target silenc-
ing (Kittler et al., 2007; Yang et al., 2002). We typically observed
esiRNA-mediated KD in > 90% of ESCs (Figure 1A and 1B).
Oct4 KD resulted in apparent differentiation of nearly all cells
(Figure 1A), consistent with previous reports (Hough et al.,
2006; Velkey and O’Shea, 2003). Furthermore, KD of Polr2A,
the large subunit of RNA Polymerase II, resulted in extensive
cell death (Figure 1A). Therefore, esiRNAs are highly effective
in RNAi-mediated gene silencing in ESCs.
Next, we produced esiRNAs directed against most known or
predicted chromatin structural and regulatory proteins as wellCell 134, 162–174, July 11, 2008 ª2008 Elsevier Inc. 163
Table 1. Targets with RNAi Phenotypes
Gene Name
Colony Morphology
Phenotype Viability Defecta Knockout Phenotypeb Protein Complex Known or Predicted Function
Rnf2c slightly flattened 3 embryonic lethality Prc1 histone ubiquitylation
Mettl5 slightly flattened 2 DNA, RNA, or ribosomal
protein methylase
Setd8c none 4 histone H4K20 methyltransferase
Brca1 vertical growth 1 peri-implantation
lethality
E3 ubiquitin ligase
Sp1 vertical growth 0 embryonic lethality transcription factor
Ighmbp2 none 4 transcription regulation
Mbd3c vertical growth 0 peri-implantation
lethality
NuRD histone deacetylation,
nucleosome remodeling
Sin3ac none 4 embryonic lethality Sin3 HDAC scaffold for histone deacetylases
Arid4a slightly flattened 2 peri-natal lethality RB-containing recruitment of HDAC
Cbx3c slightly flattened 3
Brd4 none 3 peri-implantation
lethality
P-TEFb, RFC transcription initiation, mitosis
Chaf1b none 3 CAF-I chromatin assembly
Tpr none 3 Nuclear pore complex
Tcp1 none 4 T-complex protein chaperone,
chromosome binding
Rif1 none 3 Rap1 telomere length regulation
Zcchc4 slightly flattened 0 DNA binding
Stat3 slightly flattened 1 embryonic lethality transcription factor
Ints4 none 3 Integrator RNA 30 end processing
Trim28c slightly flattened 3 embryonic lethality transcriptional corepressor
Cdc5l none 3 transcription factor
Ssrp1c none 4 peri-implantation
lethality
FACT transcriptional elongation
Supt16h none 4 FACT transcriptional elongation
Ruvbl1c flattened 3 Tip60-p400, SRCAP,
Ino80
chromatin remodeling
Ruvbl2c flattened 2 Tip60-p400, SRCAP,
Ino80
chromatin remodeling
Dmap1c flattened 1 Tip60-p400, SRCAP chromatin remodeling
Ep400c (p400) flattened 2 Tip60-p400 chromatin remodeling
Htatipc (Tip60) flattened 1 Tip60-p400 chromatin remodeling
Trrapc flattened 1 preimplantation
lethality
Tip60-p400 chromatin remodeling
Yeats4c flattened 2 Tip60-p400, SRCAP chromatin remodeling
H2afz none 1 embryonic lethality chromatin structure
Smarcc1 slightly flattened 0 peri-implantation
lethality
BRG1 nucleosome remodeling
Smarca4c slightly flattened 0 embryonic lethality BRG1 nucleosome remodeling
Arid1a slightly flattened 0 BRG1 nucleosome remodeling
Smc1a slightly flattened 1 cohesin chromosome cohesion
Smc2 none 4 condensin I,
condensin II
Mitotic chromosome
condensation
Smc4c none 4 condensin I,
condensin II
Mitotic chromosome
condensation
Gmnn none 4 preimplantation
lethality
DNA replication164 Cell 134, 162–174, July 11, 2008 ª2008 Elsevier Inc.
Table 1. Continued
Gene Name
Colony Morphology
Phenotype Viability Defecta Knockout Phenotypeb Protein Complex Known or Predicted Function
Mcm7 none 3 Mcm2-7 helicase DNA replication
Mcm2c none 3 Mcm2-7 helicase DNA replication
Mcm6 none 3 Mcm2-7 helicase DNA replication
Mcm4 none 3 preimplantation
lethality
Mcm2-7 helicase DNA replication
Eif4a3c none 4 exon junction complex NMD, ribosome biogenesis
Ddx54 none 4 Ribosome biogenesis
Ddx56 none 2 Ribosome biogenesis
Ddx18c none 4 Ribosome biogenesis
Ddx47c none 3 Ribosome biogenesis
Utp3 slightly flattened 2 processome, ribosome
biogenesis
Snrpd1 none 4 core spliceosome RNA splicing
Snrpd2 none 4 core spliceosome RNA splicing
Snrpd3 none 4 core spliceosome RNA splicing
Snrpe none 4 core spliceosome RNA splicing
Snrpfc none 4 core spliceosome RNA splicing
Snrpg none 4 core spliceosome RNA splicing
Snrpn none 4 post-natal size
alteration
core spliceosome RNA splicing
Lsm2c none 3 core spliceosome RNA splicing
Lsm6d none 4 core spliceosome RNA splicing
Lsm7 none 3 core spliceosome RNA splicing
Dhx15 none 3 RNA splicing
Ascc3l1 none 4 U5 snRNP RNA splicing
Skiv2l2 none 3 spliceosome RNA splicing
Ddx41 none 3 spliceosome RNA splicing
Dhx37 none 3
Dhx8 none 4 RNA splicing
Ddx39 none 4 spliceosome RNA splicing
Aqr none 4 spliceosome RNA splicing
Sf3b1 none 4 preimplantation
lethality
spliceosome RNA splicing
Phf5a none 4 spliceosome RNA splicing
Ddx19a none 4 mRNA export
aNumerical scale of cell division/viability defects: 0, no effect; 1, minor; 2, moderate; 3, moderate to severe; 4, severe.
bReferences in Table S2.
c Phenotype validated with second esiRNA (20 of 20 tested).
d esiRNAs target Lsm6 and LOC635563 (predicted Lsm6 homolog).as proteins with motifs common to chromatin regulators (Table
S1 available online), and transfected them individually into
mouse ESCs. Each KD was scored for defects in viability and al-
terations in cell or colony morphology in two different ESC lines,
each tested twice. We resynthesized esiRNAs for genes exhibit-
ingaphenotype inoneorbothESC lines in theprimary screenand
repeated the KDs in both ESC lines. Of 1008 targets screened, 68
exhibited reproducible phenotypes in both ESC lines (Table 1). To
validate the hits we retested 20 with a second, independent
esiRNA. All 20 reproduced the original phenotype (Table 1). Fur-thermore, the same KD phenotype was observed with individual
components of several known multi-subunit complexes. These
data strongly suggest that we identified few false positives.
Although several of the 68 genes exhibit early embryonic lethality
in knockoutmice (Table 1),most of thesegeneshadnopreviously
known roles in ESCs, demonstrating the utility of the screen.
We observed three classes of KD phenotypes: death, alter-
ations in ESC morphology, or alterations in colony morphology
(Table 1). The most prevalent KD phenotype was cell death,
common among targets that are important for fundamentalCell 134, 162–174, July 11, 2008 ª2008 Elsevier Inc. 165
cellular processes, such as transcriptional elongation, chromo-
some condensation, DNA replication, splicing, ribosome bio-
genesis, and mRNA export. Depletion of several chromatin re-
gulatory proteins, including histone modifying enzymes,
nucleosome remodeling factors, and chromatin assembly pro-
teins also reduced ESC viability (Figure 1C). In addition, KD of
19 genes within this class of targets caused alterations in ESC
morphology (Figure 1C), which can indicate a defect in self-re-
newal (Chambers et al., 2003; Kaji et al., 2006; Mitsui et al.,
2003; Niwa et al., 1998, 2000). For example, depletion of the plu-
ripotency TF Stat3, resulted in flattened and elongated cells that
grew in a monolayer (Figure 1C). Finally, a small group of KDs,
Mbd3, Brca1, and Sp1, resulted in ESC colonies that grew well
in the vertical direction, but did not expand well horizontally
(Figure 1C). Mbd3/ ESCs are defective in differentiation (Kaji
et al., 2006), suggesting a link between the vertical colony growth
and the inability to respond to differentiation cues. Determining
how the targets that are important for normal cell or colony
morphology function in ESCs should provide new insights into
mechanisms that regulate pluripotency and self-renewal.
Tip60-p400 Is Necessary for Maintenance
of ESC Identity
We characterized the group of hits with the most prominent cell
morphology KD phenotype. Seven components of the Tip60-
p400 HAT and nucleosome remodeling complex, which func-
tions in transcriptional regulation and DNA repair (Sapountzi
et al., 2006; Squatrito et al., 2006), exhibited the same unique
KD phenotype. Upon depletion of any of these factors, cells
exhibited a flattened and elongated morphology, reduced cell-
cell contact and growth in a monolayer (Figures 2A and S1).
This contrasts with the normal ESC growth pattern, in which
small spherical cells grow in dense, three-dimensional colonies.
In human fibroblasts, KD of p400 results in upregulation of the
CDK inhibitor p21, which causes G1 arrest and premature se-
nescence (Chan et al., 2005). In contrast, ESCs depleted
of any of several Tip60-p400 subunits continued to cycle, with
a reduction in S-phase cells (Figure 2B), an increase in the G2
population, a reduction in proliferation rate (Figure 2D), and no
detectable upregulation of p21 (Figure S2). The effect of Tip60-
p400 depletion on proliferation was unique to ESCs, as the dou-
bling time, cell morphology and p21 levels of KD primary mouse
embryo fibroblasts (MEFs) were similar to controls, despite a
modest effect on their cell cycle (Figures 2E–2G).
In light of the unusual morphology of Tip60-p400 KD ESCs, we
assayed whether other characteristics of ESCs were altered
upon KD. Alkaline phosphatase (AP) activity is high in undifferen-
tiated ESCs and becomes weaker upon differentiation (Martin
and Evans, 1975). ESCs depleted of Tip60-p400 subunits ex-
hibited weak AP staining relative to controls (Figure 3A). Another
feature of ESCs is the ability to aggregate in suspension to form
embryoid bodies (EBs) (Martin and Evans, 1975). To test whether
Tip60-p400 is important for this process, we placed mock,
Tip60, or p400 KD ESCs in hanging drops and scored whether
they aggregated within 24 hr (Figure 3B). Control cells formed
EBs in almost every drop, while most Tip60-p400 KD ESCs
remained dispersed, indicating that Tip60-p400 KD ESCs gener-
ally failed to aggregate to form EBs. In addition, ESCs infected166 Cell 134, 162–174, July 11, 2008 ª2008 Elsevier Inc.with lentiviruses expressing shRNAs specific for the Dmap1 sub-
unit of the Tip60-p400 complex also failed to aggregate, while
ESCs infected with a control virus aggregated normally (Fig-
ure 3B). Consistent with a defect in aggregation, the few
Tip60-p400 KD EBs present after 4 days were much smaller
than controls (Figure S3).
A defining feature of ESCs is pluripotency. To assess pluripo-
tency of Tip60-p400 KD ESCs, we infected ESCs with Dmap1
shRNA lentiviruses and tested whether these ESCs could form
normal teratomas. While the shRNAs silenced Dmap1 effec-
tively, there was a strong selection against Dmap1 silencing,
as ESCs infected with these viruses regained Dmap1 expression
after moderate passaging in culture (Figure S4). As with the cul-
tured ESCs, teratomas from Dmap1 shRNA-expressing ESCs
exhibited reactivation of Dmap1 expression (Figure S4). Despite
this reactivation, Dmap1 shRNA-expressing ESCs formed tera-
tomas that were much smaller (Figure 3C) and less complex
than controls, with limited representation of cell types from all
three germ layers (Figure S4). These data indicate that Dmap1
expression is necessary for robust proliferation or differentiation
of ESCs in teratomas, suggesting a partial defect in pluripotency.
In summary, ESCs depleted of Tip60-p400 complex have de-
fects in three distinguishing features of ESCs: AP activity, EB
formation and teratoma formation. These defects, combined
with the altered cellular and colony morphology, cell cycle and
growth rate upon Tip60-p400 KD indicate that this complex is
necessary for maintenance of normal ESC identity. Consistent
with these results, mouse embryos homozygous for deletion of
Trrap or Htatip (Tip60), which encode subunits of the Tip60-
p400 complex, die before implantation (Gorrini et al., 2007;
Herceg et al., 2001) and Trrap mutant ESCs exhibit phenotypes
comparable to those of Tip60-p400 KD ESCs (Z. Herceg,
personal communication).
Tip60-p400 Represses Transcription of Genes Induced
during Development
To gain insight into the transcriptional role of the Tip60-p400
complex in maintenance of ESC identity, we examined changes
in ESC gene expression upon KD of Tip60 or p400. 802 genes
were differentially expressed in both Tip60 and p400 KD ESCs,
including 128 downregulated and 674 upregulated genes (Tables
S3 and S4), suggesting that Tip60-p400 acts as a transcriptional
repressor at most of its targets. RT-qPCR for ESCs depleted of
different Tip60-p400 subunits showed similar effects on expres-
sion of several genes tested (Figure S5), arguing that the whole
Tip60-p400 complex is necessary to repress transcription.
Genes misregulated in Tip60-p400 KD ESCs were signifi-
cantly enriched for a number of functional categories (Figure 4A,
Table S5). Downregulated genes were enriched for cell-cycle
regulators, metabolic genes and genes required for cell divi-
sion, which could be either a cause or consequence of the
cell cycle phenotype observed upon KD of Tip60-p400 subunits
(Figure 2B). In contrast, upregulated genes were enriched for
several categories relating to differentiation and embryonic
development (Figure 4A).
Although p400 KD ESCs lack many features of normal, plurip-
otent ESCs and express a large number of developmental genes,
we did not observe a significant decrease in mRNA levels of ESC
markers Rex1/Zfp42, Sox2,Utf1, Esg1/Dppa5, Stat3, orCripto1/
Tdgf1 (Tables S3 and S4) or in protein levels of Oct4 and Nanog
(Figure 4B). Therefore, Tip60-p400 depleted ESCs simulta-
neously express differentiation and pluripotency genes. In princi-
ple, these data could be explained by the presence of a small
percentage of differentiated cells in an otherwise normal ESC
population. However, there was no obvious heterogeneity within
the Tip60-p400 knockdown population, which uniformly ex-
hibited a flattened and elongated cell morphology. In addition,
there was no notable cell-to-cell variation in levels of Oct4 for
both themock and Tip60-p400 KD populations (data not shown).
This suggests that Tip60-p400depletedESCsself-renew inan in-
termediate state, lacking most of the defining features of ESCs
(Figures 2, 3, S1, S3, and S4), but fail to fully differentiate. Several
possibilities can account for this result. First, developmental cues
present during differentiationmaybe required for downregulation
of pluripotency genes. Second, Tip60-p400 may be required to
repress both differentiation genes in ESCs and ESC-specific
genes upon differentiation. Third, Tip60-p400 may function
Figure 2. Phenotypes of ESCs and MEFs
Depleted of Tip60-p400 Subunits
(A) Brightfield images of ESCs depleted of six
Tip60-p400 subunits, as well as H2AZ or EGFP
as controls. Scale bars equal 120 mm.
(B) Cell cycle profiles of ESCs depleted of the indi-
cated proteins. The percentage of cells in S-phase
is indicated within each plot. Shown is one of two
experiments with similar results.
(C) Western blotting of indicated proteins from
ESCs transfected with the indicated esiRNAs.
(D) Growth curve of ESCs treated with indicated
esiRNAs. Shown is one of two experiments with
similar results.
(E) Western blotting of indicated proteins from
MEFs transfected with the indicated esiRNAs.
The asterisk indicates a background band.
(F) Cell cycle profiles of MEFs depleted of the
indicated proteins.
(G) Growth curve of MEFs treated with indicated
esiRNAs. Shown is one of two experiments with
similar results.
downstream of ESC-specific TFs, such
that Tip60-p400 depletion perturbs ESC
identity without affecting expression of
known self-renewal and pluripotency
master regulators. We explored the last
possibility further.
Tip60-p400 and Nanog Regulate
Overlapping Sets of Genes
To better understand the function of
Tip60-p400 in regulation of the ESC tran-
scription program, we compared the
Tip60 and p400 KD expression profiles
to those of factors known to function in
ESCs. There was significant overlap be-
tween the sets of genes misregulated in
Tip60-p400 KD and Nanog KD, but not
between those in Tip60-p400 KD and Oct4 KD, Suz12 knockout,
Oct4 overexpression or repression, or Sox2 repression (Fig-
ure 4C). We used principal component analysis to graphically
project the correlations between the Tip60-p400 KD expression
data and these other expression profiles (Figure 4D; Table S6).
The Tip60 and p400 KD expression profiles were again distinct
from those of Oct4, Sox2 and Suz12. In contrast, the Nanog
KD expression profile overlapped partially with both the Oct4/
Sox2/Suz12 group and the Tip60-p400 group, indicating that
Tip60-p400 depletion induces changes in expression compara-
ble to Nanog depletion for many genes that are unaffected in the
other data sets.
Given the overlap between the Tip60-p400 and Nanog KD ex-
pression profiles, we examined whether these factors function in
the same pathway or in different pathways to repress develop-
mental genes. ESCs were depleted of p400, Nanog, or both
and mRNA levels were analyzed. For some genes (Dkk1,
Snai1,Myc, Scamp1), simultaneous KD of both p400 and Nanog
increased expression to levels similar to p400 KD aloneCell 134, 162–174, July 11, 2008 ª2008 Elsevier Inc. 167
Figure 3. Tip60-p400 Is Required for Maintenance of ESC Identity
(A) AP staining of ESCs transfected for four days with the indicated esiRNAs. Scale bars equal 100 mm. (B) EB formation. Mock transfected, p400 KD, or Tip60 KD
ESCs were aggregated in hanging drops. Alternatively, ESCs infected with an empty vector lentivirus or lentivirus expressing the Dmap1-A shRNA were aggre-
gated. (Top) Brightfield images of empty vector (left) or Dmap1-A shRNA (right) ESCs. Scale bars equal 40 mm. (Bottom) Percentage of hanging drops in which
ESCs aggregated or remained dispersed after 24 hr.
(C) Tumor mass of teratomas formed from ESCs infected with lentiviruses expressing Dmap1 shRNAs or empty vector lentiviruses 21 days after injection into
nude mice.(Figure 4E). In contrast, two master regulators of primitive endo-
derm differentiation,Gata4 andGata6 (Fujikura et al., 2002), were
more severely affected in the double KD than in either single KD.
A few genes (Akr1b8,Nefl,Nodal) exhibited intermediate effects.
These data suggest that Nanog and Tip60-p400 function
together to regulate a common set of genes.
p400 Localization Strongly Correlates with H3K4me3
at Both Active and Silent Genes in ESCs
We next performed p400 chromatin immunoprecipitation and
hybridization to promoter tiling arrays to determine which genes
misregulated upon Tip60-p400 KD were bound by this complex
in ESCs (Table S7). We observed high confidence binding of
p400 at 55% of all promoter regions (Figure S6). These results
were validated by PCR for several targets (Figure 5A).
Since p400 was enriched at most promoters, we examined
whether p400 occupancy correlated with gene expression or
abundant histonemodifications. There was a positive correlation168 Cell 134, 162–174, July 11, 2008 ª2008 Elsevier Inc.between p400 enrichment and gene expression (r = 0.64); the
most highly expressed genes showed the greatest enrichment
for p400 (Figure 5B). Despite the fact that p400 binds 55% of
all promoters in ESCs, we also observed a significant overlap
between p400-bound promoters and genes whose expression
is affected by p400 KD (Figure S7).
While the magnitude of p400 enrichment at promoters gen-
erally correlated with the level of gene expression, PcG tar-
gets were a notable exception (Figure S8). PcG targets are
unusual among silent genes in ESCs, in that they have chro-
matin modifications associated with silent (H3K27me3) and
active (H3K4me3) genes (Bernstein et al., 2006). There was
a strong positive correlation between H3K4me3 and p400
levels at promoters (r = 0.77) (Figure 5C). Furthermore, most
PcG targets are enriched for p400 (Figure 5D). These data
suggest that p400 binds to promoters marked by H3K4me3,
including both highly expressed genes and targets of PcG
repression.
H3K4me3 and Nanog Independently Promote
p400 Binding
The strong correlation between H3K4me3 and p400 localization
raised the possibility that this mark may be necessary for p400
to bind its target promoters. To test this possibility, we made
use of the fact that mammalian SET1-like complexes (which cat-
alyze H3K4me3) all contain several common subunits, including
Ash2l and Wdr5 (Dou et al., 2006). We therefore tested the effect
of Ash2l KD on binding of p400 to its target promoters. Ash2l KD
sharply reducedH3K4me3 levels, but had noeffect on expression
of p400 orDmap1 (Figure 5F). Bindingof p400 to its chromatin tar-
gets was significantly reduced in Ash2l KD ESCs (Figure 5E), sug-
gesting that H3K4me3 is necessary for normal levels of chromatin
Figure 4. Overlapping Functions of Tip60-
p400 and Nanog Revealed by Expression
Profiling
(A) The significance of enrichment of a subset of
Gene Ontology (GO) terms common among genes
misregulated in p400 KD ESCs. Similar categories
were enriched in the Tip60 KD dataset.
(B) Protein levels of Tip60-p400 subunits (p400,
Dmap1), TFs (Oct4, Nanog), and a loading control
(cyclophilin B, CypB) were determined byWestern
blotting. The asterisk indicates a background
band.
(C) Comparison of ESC expression profiles upon
KD, knockout (KO), inducible repression (rep) or
overexpression (oex) of the indicated factors
(Loh et al., 2006; Masui et al., 2007; Matoba
et al., 2006; Pasini et al., 2007). p-values (one-
sided Fisher’s exact test) indicating statistical
significance of overlap with Tip60 or p400 KD are
shown.
(D) Principal component analysis of gene expres-
sion profiles from (C).
(E) RT-qPCR measuring mRNA levels of Nanog-
and Tip60-p400-target genes (indicated below) in
ESCs depleted of p400, Nanog, or both, relative
to control (EGFP)-depleted ESCs. Data are repre-
sented as mean ± SD.
binding by Tip60-p400. Similar effects on
p400 binding were also observed upon
KD of Wdr5 (data not shown).
We next examined the basis of the
overlap between the Nanog and Tip60-
p400 KD expression profiles. We con-
sidered the possibility that Nanog
regulates binding of Tip60-p400 to chro-
matin in ESCs, perhaps by regulation of
H3K4me3 levels at Tip60-p400 target
promoters. To test this possibility, we ex-
amined the localization of p400 and
H3K4me3 to p400 targets upon Nanog
KD. H3K4me3 levels at p400 target pro-
moters ranged from unaffected to slightly
increased in Nanog KD ESCs (Figure 6A),
indicating that Nanog was not required
for deposition of the H3K4me3 mark. In
contrast, p400 binding to its targets was significantly reduced
in Nanog-depleted ESCs (Figure 6B). Nanog depletion does
not significantly affect mRNA levels of components of the
Tip60-p400 complex (Loh et al., 2006) or protein levels of p400
and Dmap1 (Figure 6C), suggesting that Nanog is necessary
for Tip60-p400 to bind its targets efficiently. Nanog KD ESCs
showed no signs of differentiation and had levels of Oct4 protein
and AP activity that were indistinguishable from controls
(Figure 6C and S9), consistent with the recent finding that
Nanog/ ESCs remain undifferentiated, albeit less robustly
(Chambers et al., 2007). These data indicate that the alteration
in p400 binding is unlikely to be due to differentiation of ESCs
upon Nanog KD. In addition, the differences in KD phenotypesCell 134, 162–174, July 11, 2008 ª2008 Elsevier Inc. 169
between Nanog and Tip60-p400 strongly suggest that Tip60-
p400 has Nanog-independent functions important for mainte-
nance of ESC identity. The reduction in p400 binding upon
Nanog KD occurred at p400 targets regardless of whether they
were also Nanog targets, suggesting that Nanog does not
directly recruit p400 to target promoters. We observed no effect
of p400 depletion on Nanog binding or H3K4me3 levels at p400
targets (data not shown). In sum, these data indicate that
H3K4me3 is necessary, but not sufficient, for targeting of Tip60-
p400. H3K4me3 is not required for Nanog expression (Figure 5F),
nor is Nanog required for H3K4me3 deposition (Figures 6A and
6C). Therefore, Nanog and H3K4me3 appear to act indepen-
dently to promote binding of Tip60-p400 to its targets.
Figure 5. Genome-Wide Location Analysis
of p400
(A) PCR verification of p400 ChIP at genes with
varying enrichment of p400. ‘‘p400 binding’’ plots
p400 enrichment (y axis) for each probe (x axis)
tiling the promoters indicated.
(B) p400 enrichment was plotted relative to the
TSS. Genes were binned into quintiles based on
expression level in ESCs, ranging from highly
expressed genes (black) to nonexpressed genes
(lightest gray).
(C and D) Density scatterplots of each gene
promoter average for p400 enrichment versus
H3K4me3 (Maherali et al., 2007) (C) or
H3K27me3 (Maherali et al., 2007) (D) enrichment.
Direct targets of Polycomb repressive complex 2
(PRC2) (Boyer et al., 2006) are indicated with black
dots. The dashed line separates p400-enriched
from nonenriched genes, as in Figure S6.
(E) ChIP in Ash2l or EGFP KD ESCs for p400 mea-
sured by qPCR and expressed as a percentage of
input. The dashed line separates p400 target
genes (according to genome-wide location data
and confirmed for several genes in Figure 5A)
from a gene without p400 enrichment (Speer2),
included as a control. IgG control qPCRs were
near zero (Figure S12). Data are represented as
mean ± SD.
(F) Western blotting for the proteins indicated in
EGFP and Ash2l KD ESCs.
Tip60-p400 Complex Promotes
Histone H4 Acetylation at Both
Active and Silent Target Promoters
Twomajor functions of Tip60-p400, H2AZ
incorporation and histone acetylation, are
thought to be associated with gene ex-
pression (Squatrito et al., 2006), yet ex-
pression profiling suggests that this com-
plex functions mainly in transcriptional
repression in ESCs. H2AZKDdid not alter
ESC morphology (Table 1 and Figure 2A),
suggesting that H2AZ deposition is not
the essential function of the Tip60-p400
complex in ESCs. Tip60-p400 is also im-
plicated in exchange of a second H2A
variant, H2AX (Ikura et al., 2007; Kusch
et al., 2004). However, as with H2AZ, H2AX loss does not pheno-
copy Tip60-p400 KD (Figure S10). Therefore, we focused on the
role of histone acetylation at targets of Tip60-p400-mediated re-
pression. BulkH4 andH2Aacetylationwere unaltered upon p400
KD (Figure S11), suggesting that Tip60-p400 may mediate its
effects in ESCs through a gene-specific mechanism.
In p400 or Tip60 KD ESCs, we observed a decrease in
histone H4 acetylation (H4ac) at the promoters of most
p400-bound genes tested (Figure 6D). These included genes
normally repressed by Tip60-p400 complex in ESCs (Gata4,
Nodal) and a gene normally expressed in ESCs whose expres-
sion is minimally affected by Tip60-p400 KD (Rps9). Therefore,
Tip60-p400 appears to acetylate histones at target promoters,170 Cell 134, 162–174, July 11, 2008 ª2008 Elsevier Inc.
regardless of whether it functions in repression of those
targets. Furthermore, these data indicate that H4ac does not
promote gene expression at targets of Tip60-p400-mediated
silencing.
DISCUSSION
We report the first large-scale RNAi screen in ESCs, targeting
most known or predicted chromatin structural or regulatory
proteins. We found 68 genes with reproducible KD phenotypes
in two different ESC lines, 22 of which exhibited alterations in
cell and/or colonymorphology,which canbe indicativeof adefect
in self-renewal. These 22 genes include members of several
Figure 6. H3K4me3 and Nanog Are Independently Required for p400
Localization
(A and B) ChIP in Nanog or EGFP KD ESCs for IgG and H3K4me3 (A) or p400
(B) at genes indicated. The dashed line separates p400 targets from a
gene without p400 enrichment, as in Figure 5E. Data are represented as
mean ± SD for (A), (B), and (D).
(C) Western blotting for the proteins indicated in EGFP and Nanog KD ESCs.
(D) ChIP in p400, Tip60 or EGFP KD ESCs for tetra-acetylated histone
H4 (H4ac) at genes indicated. IgG control qPCRs were near zero
(Figure S12).nucleosome remodeling complexes, including NuRD, Brg1 and
Tip60-p400, aswell ashistonemodifyingenzymes, transcriptional
co-regulators and chromatin binding proteins. The remaining 46
genes include some chromatin regulators, but are enriched for
chromatin structural proteins and enzymes with roles in core nu-
clear processes, such as DNA replication, chromosome conden-
sation and RNA processing. It is noteworthy that several of these
46 genes have been knockeddown in somatic cellswithout caus-
ing major defects in viability or proliferation (Baillat et al., 2005;
Cortez et al., 2004; Ono et al., 2003), suggesting that ESCs are
uniquely sensitive to certain perturbations of chromatin structure.
This is consistent with the idea that nuclear architecture, global
chromatin structure and chromatin fluidity are distinctly different
in ESCs and differentiated cells (Meshorer and Misteli, 2006).
The genes with the most prominent change in ESC morphol-
ogy upon KD each encode a subunit of the Tip60-p400 complex.
ESCs depleted of Tip60-p400 subunits exhibited phenotypes
consistent with a defect in maintenance of ESC identity, includ-
ing failure to grow in colonies, poor expression of AP, failure to
aggregate into EBs and defects in teratoma formation. Tip60-
p400 depletion has effects on the cell cycle and proliferation
rate of ESCs, which might contribute to these phenotypes.
These data represent the first demonstration that Tip60-p400
plays a role in maintenance of ESC identity. Upon KD of Tip60-
p400 4% of genes were misregulated, the majority of which
were upregulated. Misregulated genes overlapped significantly
with genes misregulated upon Nanog KD, suggesting functional
overlap of these factors. These data indicate that transcriptional
repression of developmental genes is a major function of Tip60-
p400 complex in ESCs.
While the most prominent effect of Tip60-p400 KD was upre-
gulation of differentiation genes normally silent in ESCs, we
found that p400 binds to more than half of all promoters, with
the strongest binding at genes that are actively transcribed.
Two major catalytic activities of Tip60-p400, H2AZ deposition
andHAT activity, are usually associatedwith active transcription,
which may explain why the genes bound most strongly by p400
are highly transcribed. Why then are most actively transcribed
genes only minimally affected by Tip60-p400 depletion? We
found that Tip60-p400 promotes H4ac at targets that are nor-
mally expressed in ESCs (and are not strongly affected by
Tip60-p400 KD), as well as genes that require Tip60-p400 for si-
lencing in ESCs. In light of these data, one explanation is that
H4ac might have different functions in different contexts. At
active promoters, H4ac is thought to promote transcription.
However, this may be one of several redundant marks for gene
activation, which would explain why actively transcribed targets
of p400 are minimally affected by Tip60-p400 KD. Perhaps H4ac
at inactive genes is a nonredundant mark that mediates gene si-
lencing when found in the presence of other silencing marks. Al-
ternatively, a nonhistone protein that mediates repression of
transcription may be a more important target for acetylation by
Tip60-p400 at silent genes.
p400 localization was found to closely mirror that of histone
H3K4me3: they are present at highly overlapping sets of genes
and both localize near the TSS (Figures 5B and 5C, (Maherali
et al., 2007)). Indeed, we found that p400 binding requires this
mark, consistent with in vitro data showing that Ing3, a subunitCell 134, 162–174, July 11, 2008 ª2008 Elsevier Inc. 171
of the Tip60-p400 complex, binds peptides bearing this modifi-
cation (Shi et al., 2006). In addition, binding of p400 to its chroma-
tin targets requires Nanog, despite the fact that the H3K4me3
mark remains present upon Nanog KD. Therefore, H3K4me3 is
a necessary, but not sufficient, determinant of p400 binding.
Nanog does not appear to recruit p400 by direct binding
(Wang et al., 2006 and data not shown). This is not surprising,
given that the binding sites for Nanog and p400 at common tar-
get genes do not frequently overlap (Loh et al., 2006 and data not
shown). Therefore, we propose a model in which binding of
Tip60-p400 to target promoters in ESCs is regulated by at least
two mechanisms, direct binding to H3K4me3 and an indirect
mechanism that depends on Nanog. The Nanog-dependent de-
terminant of p400 binding could be mediated by a number of
mechanisms. Nanog could promote expression of a transcription
factor that directly recruits Tip60-p400 to specific targets that
also contain H3K4me3. Alternatively, Nanog could regulate
one or more enzymes that covalently modify and promote stabi-
lization of the complex. However, no matter the mechanism by
which Nanog regulates p400 binding, our data show that
Tip60-p400 is an important effector of Nanog-mediated
transcriptional repression, integrating signals from at least two
different pathways to regulate gene expression in ESCs.
While Nanog expression is relatively restricted, Tip60-p400 is
broadlyexpressed. Itwill be interesting to investigatehowthe func-
tionof Tip60-p400 indifferentiatedcells differs from its role inESCs
and how Tip60-p400 chromatin binding and enzymatic activities
are regulated during development. Also, humanNANOG is among
the group of TFs that can direct reprogramming of differentiated
cells into induced pluripotent stem (iPS) cells (Yu et al., 2007), re-
vealing thatectopically expressedNANOGcan function indifferen-
tiated cells. Determining whether NANOG can promote chromatin
binding of human TIP60-p400 in differentiated cells, and whether
TIP60-p400 is necessary for generation of iPS cells may provide
important insights into the events that mediate reprogramming.
Here, we have used RNAi to screen for chromatin proteins
necessary for normal ESC growth. ESCs hold considerable
promise for the treatment of disease. Characterization of path-
ways important for ESC self-renewal and differentiation will be
essential to their possible therapeutic use. Besides Tip60-p400,
we have identified a number of proteins that are likely involved
in these processes—understanding how these proteins regulate
and are regulated by self-renewal, differentiation and reprogram-
ming pathways will be an important next step.
EXPERIMENTAL PROCEDURES
Embryonic Stem Cells
ESC lines used in this study were E14 (Hooper et al., 1987); E14-EGFP, con-
structed by integration of pEGFP-C1 in E14 cells; Oct4-GiP (provided by A.
Smith); E14-H2A-GFP, constructed by integration of pBOS-H2A-GFP (pro-
vided by D. Nusinow); and H2AX/ (Bassing et al., 2002).
Construction of esiRNA Library and RNAi
Most known or predicted chromatin proteins in mouse were identified by
searching the NCBI Gene database for genes encoding proteins with known
roles in chromatin structure or regulation or for those with domains common
among chromatin regulators. Templates for esiRNA production were pro-
duced using a two-step PCR procedure (Foley and O’Farrell, 2004). In vitro
transcription was performed with T7 RNA polymerase and dicing of double172 Cell 134, 162–174, July 11, 2008 ª2008 Elsevier Inc.stranded RNA was performed using RNase III. esiRNAs were transfected
into ESCs using Lipofectamine2000. See Supplemental Data for details.
Cell Cycle Analysis
Cell cycle profiling of propidium iodide stained cells was performed as
described (Benanti et al., 2002). Fractions of cells in S-phase were quantified
using FlowJo software.
Alkaline Phosphatase Staining
ESCs were transfected with esiRNAs for 4 days (except where noted) and
stained for AP activity using a kit (Chemicon) according to the manufacturers
instructions.
Embryoid Body Generation
EBs were made by placing 10 ESCs in a 20 ml volume and suspending the
drops upside down over a bath of PBS. For p400 or Tip60 KD EBs, ESCs
were mock transfected or transfected with p400 or Tip60 esiRNA, and after
24 hr were trypsinized and placed in hanging drops. For Dmap1 KD EBs, nor-
mal ESCs infected with Dmap1 shRNA lentiviruses (in pSICOR vector; Ventura
et al., 2004) or control virus were placed in hanging drops. After 24 hr, each
drop was scored for whether the ESCs had aggregated.
Teratomas
ESCs were infected with lentiviruses expressing either no shRNA or one of two
shRNAs targeting the Dmap1 subunit of Tip60-p400. Infected cells were puri-
fied by FACS and injected into the posterior flanks of nude mice (53 106 cells
per injection). After 21 days, mice were sacrificed. Tumors were weighed, fixed
in 4% paraformaldehyde, sectioned and stained with hematoxylin and eosin.
Expression Profiling
RNA was isolated using Trizol reagent combined with PureLink Micro-to-Midi
columns (Invitrogen). Labeled material was hybridized to whole mouse
genome 4x44K Ink-jet arrays (Agilent). See Supplemental Data for details.
Chromatin Immunoprecipitation
For chromatin Immunoprecipitation (ChIP), we used 1 or 0.25 mg of formalin-
crosslinked chromatin for genome-wide location analysis or qPCR, respec-
tively. ChIP was performed essentially as described (Fazzio et al., 2005) with
a few modifications (Supplemental Data). Genome-wide location analysis
was carried out using Mouse MM8 promoter arrays (NimbleGen; 50 base
probes tiling every 100 base pairs from 3250 base pairs upstream to 750
base pairs downstream of each TSS). See Supplemental Data for details.
RT-qPCR and ChIP-qPCR
RT-qPCR: Cells were transfected with esiRNAs for 72 hr and total RNA was
extracted. Reverse transcription was performed for 1 hr using random priming.
RT-qPCR was performed in 25 ml reactions using 0.5 ml of cDNA. qPCR reac-
tions (13 AmpliTaq Gold Buffer, 1.5 mM MgCl2, 0.2 mM dNTPs, 0.2 mM each
primer, SYBR green, Taq enzyme) were performed on a Stratagene Mx3000P
qPCR system, using primers specific for each gene. Data were normalized to
a loading control (Cyclophilin B).
ChIP-qPCR: Dilutions of input and IP were analyzed as above and the
percentage of input in the IP sample was calculated from the relative copy
numbers. Oligonucleotides used in RT-qPCR and ChIP-qPCR are listed in
the Supplemental Data.
ACCESSION NUMBERS
The data discussed in this publication have been deposited in NCBI’s Gene
Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) and are acces-
sible through GEO Series accession number GSE11243.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, Supple-
mental References, twelve figures, and seven tables and can be found with
this article online at http://www.cell.com/cgi/content/full/134/1/162/DC1/.
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